Security Snapshot

Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO) Institutional Ownership

CUSIP: 05368M106

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$12.49

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
64,369,712
SEC-reported price per share
$12.49
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 05368M106.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
  • SEC-reported value moved from $1,531,725 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

05368M106

Latest holder period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
CDMO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AltraVue Capital, LLC 5.9% $47,190,485 3,797,813 AltraVue Capital, LLC 31 Dec 2024

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
35
Latest
n/a
Rows shown
1-25 of 35
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$1,531,725 $12.49 0
2025 Q3 134,598 $1,531,725 +$1,531,725 $11.38 1
2025 Q2 0 $0 -$2,310 $12.49 0
2025 Q1 187 $2,310 -$824,589,287 $12.43 2
2024 Q4 67,862,725 $838,118,292 +$9,853,050 $12.35 195
2024 Q3 68,016,155 $773,947,096 +$65,075,263 $11.38 171
2024 Q2 65,072,173 $464,610,616 +$2,556,922 $7.14 167
2024 Q1 65,068,905 $435,959,854 +$52,291,806 $6.70 162
2023 Q4 57,332,577 $373,979,029 -$54,052,092 $6.50 171
2023 Q3 62,604,660 $590,964,703 -$26,582,219 $9.44 166
2023 Q2 64,851,861 $906,098,576 -$203,208 $13.97 164
2023 Q1 64,584,658 $1,211,388,533 -$7,196,779 $18.76 166
2022 Q4 65,304,421 $899,318,344 +$3,894,302 $13.77 162
2022 Q3 64,309,645 $1,229,047,447 +$30,714,400 $19.12 168
2022 Q2 61,099,678 $932,609,878 -$12,928,155 $15.26 180
2022 Q1 61,944,273 $1,262,212,725 -$11,767,975 $20.37 182
2021 Q4 61,292,159 $1,785,416,483 +$224,167,054 $29.18 184
2021 Q3 53,889,335 $1,161,457,403 +$19,405,092 $21.57 154
2021 Q2 52,834,820 $1,353,592,887 +$137,037,774 $25.65 167
2021 Q1 47,706,252 $870,108,293 +$164,156,116 $18.23 152
2020 Q4 39,269,337 $453,350,286 +$67,918,429 $11.54 141
2020 Q3 33,338,151 $254,061,025 +$32,454,270 $7.62 104
2020 Q2 29,117,143 $191,764,644 +$5,672,161 $6.56 95
2020 Q1 28,279,005 $144,444,796 -$6,179,021 $5.11 89
2019 Q4 28,687,052 $219,999,260 +$25,179,108 $7.67 105
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .